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The effect of insecticide synergist 
treatment on genome-wide gene 
expression in a polyphagous pest
Simon Snoeck1, Robert Greenhalgh2, Luc Tirry1, Richard M. Clark2,3, Thomas Van Leeuwen1,4 
& Wannes Dermauw  1
Synergists can counteract metabolic insecticide resistance by inhibiting detoxification enzymes or 
transporters. They are used in commercial formulations of insecticides, but are also frequently used 
in the elucidation of resistance mechanisms. However, the effect of synergists on genome-wide 
transcription in arthropods is poorly understood. In this study we used Illumina RNA-sequencing to 
investigate genome-wide transcriptional responses in an acaricide resistant strain of the spider mite 
Tetranychus urticae upon exposure to synergists such as S,S,S-tributyl phosphorotrithioate (DEF), 
diethyl maleate (DEM), piperonyl butoxide (PBO) and cyclosporin A (CsA). Exposure to PBO and DEF 
resulted in a broad transcriptional response and about one third of the differentially expressed genes 
(DEGs), including cytochrome P450 monooxygenases and UDP-glycosyltransferases, was shared 
between both treatments, suggesting common transcriptional regulation. Moreover, both DEF and 
PBO induced genes that are strongly implicated in acaricide resistance in the respective strain. In 
contrast, CsA treatment mainly resulted in downregulation of Major Facilitator Superfamily (MFS) 
genes, while DEGs of the DEM treatment were not significantly enriched for any GO-terms.
Insecticide resistance is a major threat for the agricultural productivity of commercial crops1, and understanding 
the mechanisms underlying insecticide resistance is a high priority for the design and implementation of effective 
resistance management programs2. Resistance mechanisms can generally be classified into either (1) changes in 
sensitivity of the target-site due to point mutations, or to (2) increased metabolic detoxification through qualita-
tive or quantitative changes in enzymes involved in the detoxification process. The latter process typically occurs 
in 3 phases. In phase I the insecticide is functionalized with nucleophilic groups (a hydroxyl, carboxyl or amine 
group) to make it more reactive and water soluble. In phase II, conjugation occurs with endogenous molecules 
(such as glutathione (GSH) or sugars), further increasing the compound’s polarity. Ultimately, in phase III, the 
phase II conjugated product is excreted by cellular transporters. Cytochrome P450 monooxygenases (P450s) and 
carboxyl/choline esterases (CCEs) are well-known examples of enzymes that are responsible for phase I reac-
tions while glutathione-S-transferases (GSTs) and UDP-glycosyltransferases (UGTs) are enzymes that typically 
operate during phase II. Finally, in phase III, metabolites are often transported out of the cell by ATP-binding 
cassette (ABC) transporters and solute carrier proteins, of which a major class are proteins of the Major Facilitator 
Superfamily (MFS)3,4.
Insecticide synergists are defined as “compounds that greatly enhance the toxicity of an insecticide, although 
they are usually practically nontoxic on their own”5. They can either act as a surrogate substrate or an inhibitor 
of detoxification enzymes and transporters and, as such, are a powerful tool to investigate insecticide resistance 
mechanisms. Synergists are also of commercial interest as combining them with insecticides increases efficacy 
and aids in keeping pesticide use to a minimum6–8. As a result of the fast and widespread development of resist-
ance, coupled with the slowdown in the number of registrations of new pesticides and a new trend towards 
“greener” and more “sustainable” pest management9, a renewed interest has arisen in the identification and 
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development of plant-based synergists10–12. However, as of yet relatively few of these new synergists have made 
the transition from the laboratory to the field or greenhouse.
The most well-known and commonly used commercial insecticide synergist is the methylene dioxyphenyl 
compound piperonyl butoxide (PBO), an inhibitor of P450s. PBO has been commercially used since 1940, mainly 
in combination with pyrethroid insecticides. Its lack of specificity in P450 inhibition has contributed to its success 
as a synergist13. The inhibition mechanism of PBO consists of two phases, starting with the binding of PBO to the 
active site of the P450, followed by the formation of a quasi-irreversible inhibitor complex between the electro-
philic carbene moiety of PBO and the ferrous iron of the P450. This results in a decreased metabolic activity of 
the P450 enzyme7,14,15. Synergists such as the defoliant S,S,S-tributyl phosphorotrithioate (also known as tribufos, 
DEF or TBPT), the fungicide iprobenfos (IBP) and triphenyl phosphate (TPP) are well-known carboxyl esterase 
inhibitors16,17. These organophosphorus compounds (OPs) behave like the natural substrate of esterases and enter 
the active site where they covalently bind to the serine –OH group. Subsequently, the OP is split, with the enzyme 
being non–reversibly phosphorylated, and regeneration of the free enzyme by hydrolyzation not possible18,19. An 
additional major synergist is the carbonyl compound diethyl maleate (DEM) that is known to conjugate reduced 
glutathione (GSH), thereby depleting cells of this tripeptide. As a consequence, it reduces the ability of GSTs 
to utilize GSH for conjugation with insecticides or with the oxidative stress products they induce20–22. Finally, 
verapamil and cyclosporin A are well-known first generation modulators (competitive inhibitors) of vertebrate 
P-glycoproteins (ABC transporters of the B subfamily)23–25. Human P-glycoproteins are well-known for their role 
in protecting tissues from toxic xenobiotics and endogenous metabolites26 and in the last decade their counter-
parts in arthropods have also been linked to insecticide transport and/or resistance27,28. For example, pretreat-
ment with verapamil has been shown to markedly enhance the toxicity of DDT or abamectin in Drosophila29,30.
Synergists, however, do not always act as intended or expected. A frequently reported unanticipated effect is 
an altered cuticular penetration of the insecticide after pretreatment with a synergist31–34. In some cases, syner-
gists might also inhibit non-target enzyme systems. PBO has been reported to act as an inhibitor of esterases in 
Helicoverpa armigera, Frankliniella occidentalis and Bemisia tabaci35–37 and as an inhibitor of mammalian UGTs38, 
while DEF was shown to act, albeit to a much lower extent compared to PBO, as an inhibitor of P450s in Blatella 
germanica34. These studies suggest that in some cases caution should be applied in interpreting results of syner-
gist application as they are not entirely specific to a single detoxification enzyme class37,39,40. However, inhibition 
of these non-target enzyme systems typically occur in a non-specific way at high synergist concentrations41,42, 
and results can be cross-checked. For example, confirmation of P450 rather than esterase inhibition by PBO is 
straightforward and can be done with another class of P450 inhibitors13.
Insects and mites are known to display a massive and rapid reprogramming of gene expression in response 
to xenobiotic exposure43–45. While synergist compounds are mostly used at concentrations that cause no or very 
low mortality, they are nonetheless used at high enough concentrations to cause maximal inhibition of the tar-
geted detoxification enzymes46. Hence, one might expect that synergists also induce gene expression changes on 
their own6. Little is known, however, regarding the genome-wide transcriptional changes in arthropods exposed 
to synergists. Using a full genome and a custom “detox” microarray it was found that a subset of P450s and 
GSTs, and to a lesser extent UGTs, were induced in Drosophila melanogaster upon exposure to PBO47, while, 
using Illumina RNA sequencing, a P450 was shown to be upregulated in the whitefly B. tabaci upon exposure 
to PBO + cypermethrin as compared to cypermethrin alone48. However, genome-wide transcriptional changes 
upon exposure to synergist compounds other than PBO have not been investigated in any herbivorous arthropod 
pest.
The two-spotted spider mite, Tetranychus urticae (Arthropoda: Chelicerata: Acari: Tetranychidae), is a highly 
polyphagous agricultural pest that is able to colonize more than 1100 plant species49. Further, among arthropods 
T. urticae is also considered to be the ‘‘pesticide resistance champion” based on the total number of different 
pesticides to which populations have become resistant50,51. Synergists such as PBO, DEF and DEM have been 
frequently used for the identification of metabolic resistance pathways in T. urticae52–61, and a high quality Sanger 
genome assembly is available for this mite species62. T. urticae is therefore an ideal arthropod herbivore to study 
the impact of synergists at the transcriptional level. In this study, we used Illumina HiSeq 2500 technology to gen-
erate deep paired-end, strand-specific RNA-seq reads from adult T. urticae females that were exposed for 24 hours 
to either DEF, DEM, PBO, CsA or formulation only. Subsequent differential expression (DE) analyses allowed us 
to identify genes for which expression was significantly altered upon exposure to synergists. A selection of dif-
ferentially expressed genes was validated by qPCR and for each comparison (synergist compared to formulation) 
a Gene Ontology (GO) analysis was performed to shed light on the types of genes and pathways that respond to 
synergist exposure (DEGs).
Results
Synergist bioassays and RNA-seq. Adult female mites of the JP-R strain were either not sprayed (CON) 
or sprayed with PBO (1000 ppm), DEF (500 ppm), DEM (2000 ppm), CsA (50ppm) or formulation (FORM; N,N-
dimethylformamide and emulsifier W (3:1 w/w) diluted in deionized water 100-fold) and collected after 24 hours, 
a commonly used time point in synergist studies56,63–65. Mortality for each treatment was scored, and found to be 
in line with those of previous reports for that strain56. Mites alive at 24 hours were collected for each treatment 
(PBO, DEF, DEM, CsA) and the controls (CON, FORM) and used for RNA extraction and RNA-seq library gen-
eration. Illumina sequencing generated ~82–92 million strand-specific paired end reads per sample. Alignment 
of RNA-seq reads against the T. urticae annotation resulted in an overall mapping rate of uniquely mapped reads 
of 83.01 ± 0.19 SE% across samples (Supplementary Table S1).
Principal Component Analysis (PCA). A PCA revealed that about forty percent (36.8%) of the total vari-
ation could be explained by PC1 while PC2 accounted for 25.7% of the variation (Fig. 1). Except for replicate 4 of 
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the CsA treatment, biological replicates clustered by treatment on PC1 relatively well. On the other hand, all rep-
licates of the CsA treatment clustered relatively well on PC2. Interestingly, in the PCA the expression data of PBO 
treatments clustered most closely with those of the DEF treatments, those of the FORM treatments grouped with 
those of unsprayed mites (CON), and those of the CsA treatments grouped with those of the DEM treatments.
Differential expression analysis and qPCR validation. We used DESeq2 to perform differential gene 
expression (DEG) analyses between treatments and controls (fold change (FC) ≥ 1.5 and a Benjamini-Hochberg 
adjusted p-value < 0.05)66. Between mites sprayed with formulation and unsprayed mites, only one gene 
(tetur13g00990, coding for an “orphan secreted protein”) was differentially expressed (FC of 1.53), indicating that 
the formulation on its own had no significant effect on gene expression. Next, we compared gene expression levels 
between mites treated with one of the synergists and mites that were treated with formulation only. One hundred 
and sixty-two genes were differentially expressed between mites treated with PBO and mites treated with formu-
lation, of which 77 were downregulated and 85 upregulated (Supplementary Table S2). The top twenty down- 
and upregulated genes had a FC of −2.11 to −1.74 and 1.86 to 3.33 respectively. For the DEF treatment, 174 
genes were differentially expressed, of which 69 were downregulated and 105 were upregulated (Supplementary 
Table S3). The expression level of the 20 most down- and upregulated genes varied from a FC of −2.33 to −1.73 
and 1.88 to 3.10, respectively. For the DEM treatment, 78 genes were differentially expressed, with 17 genes being 
downregulated and 61 upregulated and the expression level of the 20 most down- and upregulated genes varied 
from a FC of −2.3 to −1.5 and 1.5. to 2.1, respectively (Supplementary Table S4). Finally, for the CsA treatment, 
58 genes were differentially expressed. Forty-two of them were downregulated, while 16 were upregulated and 
the expression level of the 20 most downregulated genes varied from −3.87 to −1.72 (Supplementary Table S5). 
For a selection of genes, the differential expression analyses based on RNA-seq were consistent with differential 
expression as validated independently by qPCR (Fig. 2). As shown in Fig. 3, the majority of DEGs were not shared 
between the different treatments. Only one upregulated gene was in common for all treatments (tetur01g06580, a 
sodium dependent glucose transporter), while two upregulated genes (tetur16g03490 and tetur11g05520, coding 
for an antigen B membrane protein and CYP385C4, respectively) were shared between the PBO, DEF and CsA 
treatments. In contrast, 60 DEGs (37% and 35% of the total number of DEGs for the PBO and DEF treatment, 
respectively) were shared between PBO and the DEF treatment and had the same direction of fold change, with 
44 genes being upregulated and 16 being downregulated.
GO enrichment and cluster analysis. We next performed GO enrichment analyses for the various dif-
ferentially expressed gene sets. For the DEGs of the DEM treatment, no significantly (Benjamini-Hochberg 
adjusted p-value < 0.05) enriched GO terms were identified, while for the CsA treatment DEGs were significantly 
enriched in the GO terms “transmembrane transport” (GO:0055085) and “integral component of membrane” 
(GO:0016021) (Table 1). Inspecting the DEGs in more detail revealed that these GO terms were mainly present 
in genes coding for transporters of the major facilitator superfamily (MFS, InterPro domain IPR020846) (20 out 
of 58 DEGS, 34.5%), and the majority of these MFS genes (15 out of 20) were downregulated (Supplementary 
Table S5, Supplementary Table S6, Fig. 4). Based on their best BLASTp hit in the Transporter Classification data-
base67, these MFS genes belong to either the Oxalate:Formate Antiporter Family (1/20), Proton Coupled Folate 
Transporter/Heme Carrier Protein Family (4/20), Fucose H + Symporter (5/20) or the Anion/Cation Symporter 
(10/20) MFS subfamily. The GO:0016021 term was also associated with genes coding for P450s (3 DEGs), UGTs 
Figure 1. Gene expression relationships among synergist treatments and controls. PCA plot of gene expression 
levels in untreated adult T. urticae females (CON), adult T. urticae females sprayed with formulation only 
(FORM) or adult T. urticae females exposed to synergist compounds CsA, DEF, DEM or PBO.
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(2 DEGs), cation-proton exchanger proteins (InterPro domain IPR018422, 2 DEGs) and a protein with an 
Apple-like domain (tetur25g02030, InterPro domain IPR003609). Interestingly, genes coding for ABC transport-
ers, which are known to be inhibited by CsA68, were not found among the DEGs of the CsA treatment.
DEGs of both the PBO and DEF treatment were significantly enriched in the GO terms “oxidoreduc-
tase activity, acting on paired donors, with incorporation or reduction of molecular oxygen” (GO:0016705), 
“heme binding” (GO:0020037), “monooxygenase activity” (GO:0004497), “iron ion binding” (GO:0005506), 
“oxidation-reduction process” (GO:0055114), “antibiotic metabolic process” (GO:0016999) and “transferase 
activity, transferring hexosyl groups” (GO:0016758). The first five GO terms were mainly present in genes cod-
ing for P450s (14 and 11 DEGs for the PBO and DEF treatments, respectively) while the latter two terms were 
found in UGTs (7 and 12 DEGs for the PBO and DEF treatments, respectively). Interestingly, almost all P450 and 
UGT genes (13/14 P450s and 7/7 UGTs (PBO treatment) and 10/11 P450s and 12/12 UGTs (DEF treatment)) 
were upregulated for both the PBO and DEF treatment. The majority of the upregulated P450 genes (12/13 and 
8/10 for the PBO and DEF treatments, respectively) belonged to the CYP392 family within the CYP2 clan for 
which several members were shown previously to respond strongly to acaricide selection and feeding on different 
Figure 2. qPCR validation of differentially expressed genes in adult T. urticae females after PBO, DEF or CsA 
treatment. Eight up- and five downregulated genes as assessed by differential gene expression (DESeq2) analysis 
of RNA-seq data were selected for qPCR analysis. Error bars represent the standard error of the calculated 
mean. Except for tetur40g00030 (CsA treatment), each gene was significantly differentially expressed (based 
on an unpaired t-test) compared to the reference condition (FORM). The ‘‘tetur’’ prefix was removed from T. 
urticae gene IDs for figure clarity.
Figure 3. Venn diagrams depicting overlap among differentially expressed genes of adult T. urticae females 
exposed to either PBO, DEF, DEM or CsA compared to adult T. urticae females treated with formulation only. 
Left panel: downregulated genes, right panel: upregulated genes.
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hosts44. GO:0055114 was also found in genes coding for short chain dehydrogenases (4 and 3 DEGs for the PBO 
and DEF treatments, respectively) and intradiol ring-cleavage dioxygenases (2 and 4 DEGs for the PBO and DEF 
treatments, respectively) while for the DEF treatment this term was also present in genes coding for a superoxide 
dismutase (tetur02g11180), a fatty acid synthase (tetur04g02370) and a glucose dehydrogenase (tetur03g09330). 
In addition, DEGs of the DEF treatment were also significantly enriched in the GO terms “hormone activity” 
(GO:0005179) and “integral component of membrane” (GO:0016021). The “hormone activity” term was present 
in four DEGs coding for neuropeptides (InterPro domain IPR001955 or IPR016179), while “integral compo-
nent of membrane” was present in more than 45 DEGs, including, amongst others, genes coding for P450s (10 
DEGs), MFS proteins (10 DEGs), UGTs (7 DEGs), ABC transporters (3 DEGs), neuropeptides (2 DEGs), innex-
ins (InterPro domain IPR000990, 2 DEGs) and proteins with a DUF3421 domain (InterPro domain IPR024518, 
2 DEGs) (Table 1 and Supplementary Tables S2 and S3). A cluster analysis of expression data of P450, UGT and 
MFS genes complemented the findings of our GO analyses. For both the P450 and UGT gene expression data the 
PBO and DEF treatment clustered together, while for MFS gene expression data, the CsA treatment fell outside 
the clade with all other treatments (Fig. 4).
Discussion
Gene expression changes are a major component of stress responses, and contribute to or complement alterations 
in metabolism, cell cycle progression, protein homeostasis, cytoskeletal organization, vesicular trafficking and 
modification of enzymatic activities69. Expression changes can be grouped into generic responses shared by many 
stresses, and stress-specific adaptive responses. In contrast to post-translational effects, which provide immediate 
responses, regulation of gene expression is essential for the slower, long term acclimation to and recovery from a 
stress factor69. At present, our understanding of gene expression changes in arthropods to synergist exposure is 
very limited in spite of their importance in insecticide- and acaricide-mediated control. In fact, only two studies 
have investigated genome-wide transcriptional changes in an insect upon synergist exposure. Willoughby et al. 
and Zimmer et al.47,48 studied PBO-induced gene expression changes in D. melanogaster and B. tabaci, respec-
tively. Gene expression changes upon exposure to other synergist compounds have not yet been determined.
In this study, we examined transcriptional responses in a polyphagous arthropod pest, T. urticae, upon expo-
sure to the synergist compounds PBO, DEF, DEM and CsA. The strain that was used for our experiments (JP-R, 
see Material & Methods) was shown to be resistant to the mitochondrial complex II inhibitors cyenopyrafen and 
cyflumetofen (both compounds are beta-keto nitrile derivatives belonging to IRAC Mode of Action Classification 
25 A 2,70), with cyenopyrafen and cyflumetofen toxicity strongly synergized by PBO and DEM, respectively, while 
DEF moderately synergized cyenopyrafen toxicity64. Because acaricides are typically applied 24 h after synergist 
treatment53,56,64,65, transcriptional changes were captured 24 h after exposure. In future, it would be interesting to 
also capture the transcription levels at those synergist exposure periods that have been used in previous synergism 
Treatment GO Category Description
adjusted 
p-value Subontology*
CsA GO:0055085 transmembrane transport 0 BP
CsA GO:0016021 integral component of membrane 6.72E-05 CC
PBO GO:0016705
oxidoreductase activity, acting on 
paired donors, with incorporation or 
reduction of molecular oxygen
2.68E-09 MF
PBO GO:0020037 heme binding 3.05E-08 MF
PBO GO:0004497 monooxygenase activity 3.05E-08 MF
PBO GO:0005506 iron ion binding 3.08E-08 MF
PBO GO:0055114 oxidation-reduction process 1.28E-05 BP
PBO GO:0016999 antibiotic metabolic process 8.83E-04 BP
PBO GO:0016758 transferase activity, transferring hexosyl groups 2.21
E-02 MF
DEF GO:0016758 transferase activity, transferring hexosyl groups 2.86
E-05 MF
DEF GO:0016999 antibiotic metabolic process 4.00E-05 BP
DEF GO:0005506 iron ion binding 1.45E-04 MF
DEF GO:0055114 oxidation-reduction process 3.43E-04 BP
DEF GO:0020037 heme binding 4.93E-04 MF
DEF GO:0016705
oxidoreductase activity, acting on 
paired donors, with incorporation or 
reduction of molecular oxygen
5.10E-04 MF
DEF GO:0004497 monooxygenase activity 7.96E-04 MF
DEF GO:0005179 hormone activity 1.18E-03 MF
DEF GO:0016021 integral component of membrane 1.66E-03 CC
Table 1. GO enrichment analysis of differentially expressed genes (absolute fold change ≥1.5 and Benjamini-
Hochberg adjusted p-value < 0.05) in adult T. urticae females of the JP-R strain exposed to either PBO, DEF or 
CsA compared to adult T. urticae females treated with formulation only. *BP, Biological Process; MF, Molecular 
Function; CC, Cellular Component.
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studies with T. urticae (1 h and 4 h)53,55,57–61. Finally, the observed fold changes of up- and downregulated T. urticae 
genes (ranging from −3.8 to 3.3 across all synergist treatments) were in line with those observed for B. tabaci by 
Zimmer et al.48. In contrast, fold changes of PBO induced Drosophila genes were considerably higher (ranging 
from 2 to 32)47. However, in our study a 24 h synergist pretreatment was used, while in Drosophila expression 
measurements were taken after 4 hours of synergist exposure, and with the Drosophila 16 K full genome array. 
Briefly, the Drosophila 16 K full genome array contained only one 70mer probe per gene47, confounding reliable 
estimation of fold changes71, while in our study and that of Zimmer et al.48 gene-expression levels were captured 
by Illumina RNA-sequencing.
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Figure 4. Expression heatmaps of genes coding for P450s, UGTs or MFS members in adult T. urticae females 
exposed to either DEF, PBO, DEM or CsA. The log2 transformed fold changes are relative to adult T. urticae 
females treated with formulation only and were clustered using a Euclidean distance metric and Ward’s method. 
T. urticae gene IDs are shown on the right.
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Stress responses can be induced by a variety of stressors such as extreme temperatures, elevated ion concen-
trations or toxic substances, all of which usually result in excessive amounts of denatured proteins72. The general 
stress response typically consists of an increased production or activation of antioxidant proteins (e.g. Cu/Zn 
superoxide dismutase and GSTs) and chaperone proteins (e.g. heat shock proteins)73,74, together with an increased 
mobilization of energy from storage tissues75. The latter is associated with the overexpression of numerous genes 
involved in energy production or in cellular catabolism such as NADH dehydrogenase, ATP synthase, trypsin 
and lipases76. Only one GST gene was significantly upregulated in the PBO and DEF treatment while a gene 
coding for a superoxide dismutase was downregulated in the DEF treatment. A GO enrichment analysis did 
not reveal a GO category that was in common between the different synergist treatments and that was related to 
the above-mentioned proteins. Even more, only one upregulated gene, coding for a putative sodium-dependent 
glucose transporter (tetur01g06580, member of the MFS-gene family), was in common for all treatments. Hence, 
we assume that the observed gene expression changes are not general stress responses but rather specific for the 
synergist compounds to which the mites had been exposed. However, based on PC1 of our principal component 
analysis gene expression levels of PBO and DEF treatment replicates did cluster together (Fig. 1). Even more, 
about 35% of the T. urticae DEGs that were identified for both these treatments were shared and had fold changes 
in the same direction (Fig. 3). Interestingly, about one third (15/44) of the upregulated shared DEGs coded for 
members of the P450 and UGT gene families (Fig. 4, Supplementary Table S2). For D. melanogaster, it has been 
shown that the transcription factor CncC plays an important role in xenobiotic-inducible gene expression of 
P450s, GSTs, UGTs and membrane transporters77. However, none of the T. urticae orthologs of D. melanogaster 
CncC (tetur07g06850 and tetur07g0460044) were differentially expressed after 24 h (Supplementary Tables S2,S3,S4 
and S5). In addition, T. urticae genes related to the gene coding for Drosophila Keap1 (Kelch-associated pro-
tein 1), a negative regulator of CncC, and that are downregulated in acaricide resistant and host plant adapted 
mite lines (OrthoMCL group 10254)44,45 were also not found among the DEGs of both the PBO and DEF treat-
ments. However, expression changes of T. urticae transcription factors genes78 did correlate for these treatments 
(Supplementary Figure S1), suggesting a common transcriptional regulation. Ten of these transcription factor 
genes had a fold change of more than 1.25 in both the PBO and DEF treatments and had an opposite direction 
of fold change compared to the CsA and DEM treatments (Supplementary Table S7) and, hence, might be good 
candidates to be investigated for their role in xenobiotic resistance regulation in T. urticae.
The induction of P450s upon exposure by PBO has been reported by other groups47,48,79–82. As hypothesized 
by Chan et al.81, it might be a compensation strategy for an enzyme to be upregulated upon contact with an 
inhibitor in order to minimize the effect of reduced enzyme activity. In general, several studies have shown that 
xenobiotics are able to induce expression of arthropod P450s11,44,45,48,77,83–86. In Drosophila for example, about a 
third of the P450s can be induced following xenobiotic substance feeding or topical application87. For T. urti-
cae it has been shown that the application of barbital, phenobarbital and geraniol does increase P450 activity 
in a dose-dependent way and that pretreatment with these inducers resulted in decreased acaricide toxicity88. 
Willoughby et al. suggested that the increase of detoxification enzymes by PBO might speed up insecticide toler-
ance if these detoxification enzymes could metabolize insecticides. Hence, one might question whether induction 
of T. urticae detoxification genes by synergist compounds could lead to a decreased toxicity of acaricides. In this 
study, CYP392A11 and CYP392A12 were both upregulated upon exposure of the JP-R strain by PBO. In 2015 it 
was shown that the upregulation of these genes was associated with cyenopyrafen resistance of the JP-R strain64 
and that CYP392A11 could metabolize cyenopyrafen89. Similarly, only three carboxyl/choline esterases, TuCCE06 
(tetur01g10800), TuCCE07 (tetur01g010810) and TuCCE25 (tetur04g06670), were upregulated upon exposure 
of the JP-R strain by DEF and recently it was shown that TuCCE25 was highly upregulated in the JP-R strain 
and responded to cyenopyrafen selection64. In summary, both PBO and DEF seem to induce genes coding for 
detoxification enzymes that are strongly associated/implicated in cyenopyrafen resistance of the JP-R strain. On 
the other hand, both PBO and DEF, at the same concentration and exposure period that was used in this study, 
have previously been shown to synergize cyenopyrafen toxicity64. Hence, the direct inhibition of these P450s 
and CCEs by PBO and DEF, respectively, seems to outweigh the impact of the synergists on their induction. In 
contrast, in instances where P450s or CCEs may not be involved in acaricide resistance, PBO or DEF induction 
of genes encoding enzymes that are not inhibited by the synergist compound and that are capable of metaboliz-
ing acaricides might interfere and lead to misinterpretation of synergism experiments (for example antagonism 
instead of synergism).
Both the PBO and DEF treatments resulted in an upregulation of TuGSTd14 (tetur29g00220). Of particular 
note, TuGSTd14 was also upregulated in multi-resistant T. urticae strains44 and showed affinity toward abamectin 
and a competitive type of inhibition90. In contrast, the DEM treatment did not result in the overexpression of 
GSTs. Even more, significantly enriched GO terms could not be identified for the DEM treatment. This result was 
somewhat unanticipated as it is known that depletion of GSH by DEM results in oxidative stress and destabilized 
proteins in vitro91 and that the response to oxidative stress typically consists of highly coordinated changes in gene 
expression (for example, in human carcinoma cells92). In the study by Casey et al.92, exposure to DEM resulted 
in GSH depletion below control levels from 1 h to 24 h after DEM treatment. However, although the expression 
of about 800 genes had a significant change (over two-fold at more than one time point) during this 24 h time 
course experiment, log2 fold changes of almost all genes returned to near zero at the 24 h time point92. Previously 
it was shown that a 24 h treatment with DEM strongly synergized cyflumetofen toxicity in the JP-R strain64 and 
that a GST (TuGSTd05) that was upregulated in this strain could metabolize cyflumetofen. Hence, the 24 h DEM 
exposure most likely resulted in depleted GSH levels in mites of the JP-R strain but the expression changes that 
are associated with the onset of depletion may not have been captured in our study.
The Major Facilitator Superfamily (MFS) is, along with ATP-binding cassette (ABC) transporters, one of the 
largest transporter families present in all living organisms. MFS transporters, as opposed to ABC transporters, 
use an existing electrochemical gradient instead of ATP to transport substrates (either by symport, uniport or 
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antiport) across membranes27,93. Numerous studies have pointed to the importance of ABC transporters in xeno-
biotic resistance in arthropods27,28. In the case of T. urticae, several of its 103 ABC transporter genes were differen-
tially expressed in multi-pesticide resistant strains and/or in mites transferred to a more challenging host plant94. 
MFS transporters, however, have been less studied in arthropods and it is only recently that evidence for their 
role in xenobiotic resistance in arthropods has been reported44,95. Consistent with this, 37 T. urticae MFS genes 
(belonging to either OrthoMCL group arthro10032, arthro10082 or arthro10236) were differentially expressed 
upon long term transfer of mites from bean to tomato44.
None of the 103 ABC T. urticae transporter genes were differentially expressed upon exposure to the ABC 
transporter modulator CsA. In contrast, about one third of the DEGS of the CsA treatment coded for MFS trans-
porters, including five sugar transporters. The differential expression of these sugar transporters might be caused 
by interference of cyclosporine in glucose metabolism96,97. On the other hand, the majority of the remaining dif-
ferentially expressed MFS genes showed similarity with members of the anion/cation superfamily that can trans-
port a variety of substrates98. Finally, it should be mentioned that CsA inhibition of ABC transporters is not well 
characterized in arthropods compared to vertebrates27, and the transcriptional changes that were observed might 
not reflect those that are caused by the inhibition of ABC transporters but rather by inhibition of another target 
like calcineurin (the T. urticae subunits of this target are tetur04g07540, tetur04g07560 and tetur03g06410 as 
assessed by a blastp search, E-values between E-86 and 0 with human calcineurin subunits as queries), as occurs 
in the vertebrate immune system99.
To conclude, transcriptional changes in arthropod pests exposed to synergist compounds have only been mar-
ginally studied. In this work, we exposed a polyphagous arthropod pest, T. urticae, for 24 hours to four different 
synergist compounds - PBO, DEF, DEM and CsA - and measured genome-wide gene expression changes. The 
CsA treatment resulted primarily in the downregulation of T. urticae MFS genes, while T. urticae DEGs of the 
DEM treatment were not significantly enriched for a GO term. Exposure to PBO and DEF resulted in a broad 
transcriptional response and about one third of the DEGs, including cytochrome P450 monooxygenases and 
UDP-glycosyltransferases, were shared between both treatments, suggesting modulation of a common transcrip-
tional program. Moreover, both DEF and PBO induced genes that are strongly implicated in acaricide resistance 
of the strain used in this study. Based on previous synergism toxicity studies, however, the induction of these 
detoxification genes seems not to interfere with the outcome of synergism assays, although the effects of induction 
might be relatively more important when resistance is not synergized.
Methods
Mite strains and chemicals. The JP-R strain has previously been described by Khalighi et al.64. Briefly, this 
strain is resistant to both cyenopyrafen (LC50 of 291 mg L−1) and cyflumetofen (LC50 of 146 mg L−1). In addition, 
cyenopyrafen toxicity in the JP-R strain is synergized by PBO and DEF, while DEM synergizes cyflumetofen 
toxicity64. The JP-R strain was maintained on potted bean plants, Phaseolus vulgaris L. var. Prelude, sprayed with 
200 mg a.i. cyenopyrafen L−1 (STARMITE, 30% SC) until run-off. For the week prior to collection of RNA, the 
strain was maintained on bean plants without cyenopyrafen selection pressure. The synergists DEF (97% purity), 
DEM (97% purity) and PBO (90% purity) were of analytical grade and purchased from Sigma-Aldrich (Belgium). 
CsA had a purity of more than 98% and was purchased from Enzo Life Sciences (Belgium).
Synergist bioassays. The synergist bioassays were performed as described earlier by Van Pottelberge et al. 
2009. Briefly, synergists were dissolved in a mixture of N,N-dimethylformamide and emulsifier W (alkylaryl-
polyglycolether), 3:1 w/w, respectively, and subsequently diluted with deionized water 100-fold. The concen-
trations used for PBO (1000 ppm), DEF (500 ppm) and DEM (2000 ppm) were identical to those in Khalighi 
et al. and Van Pottelberge et al.53,56 and are known to cause between 5 and 10% mortality. Based on preliminary 
experiments a concentration of 50 ppm CsA was used, resulting in maximum 5 to 10% mortality. About 30 
3–5 day old adult females were transferred to the upper (adaxial) side of a 9 cm2 square-cut kidney bean leaf discs 
placed on wet cotton wool. Leaf discs were sprayed at 1 bar pressure in a Cornelis spray tower with 650 µl spray 
fluid (1.56 ± 0.04 mg fluid deposit cm−2) containing one of the synergists (DEF, DEM, PBO, CsA) or formula-
tion (FORM; N,N-dimethylformamide and emulsifier W (3:1 w/w) diluted in deionized water 100-fold) only. 
Unsprayed mites (CON) served as an additional control. About 600 mites (20 leaf disks with mites) were used for 
each treatment (DEF, DEM, PBO or CsA) and for the controls (FORM, CON). Next, leaf disks were placed in a 
climatically controlled room at 26 °C, 60% RH with a 16:8 h light:dark photoperiod. After 24 hours, living mites 
were scored and collected for RNA extraction. Mites were scored as being alive if they could walk normally after 
being prodded with a camel’s hair brush.
RNA-seq. Total RNA was extracted from about 100 adult female mites (collected from at least four different 
leaf disks) using the RNeasy mini kit (Qiagen, Belgium) with four-fold biological replication for each treatment 
(PBO, DEF, DEM, CsA) and the controls (FORM, CON). The quality and quantity of the total RNA was analyzed 
by a DeNovix DS-11 spectrophotometer (DeNovix, USA) and by running an aliquot on a 1% agarose gel. From 
the RNA samples, Illumina libraries were constructed with the TruSeq Stranded mRNA Library Preparation Kit 
with polyA selection (Illumina, USA), and the resulting libraries were sequenced on an Illumina HiSeq 2500 to 
generate strand-specific paired reads of 2 × 125 bp (library construction and sequencing was performed at the 
High-Throughput Genomics Core of the Huntsman Cancer Institute, University of Utah, Utah, USA). Prior to 
read-mapping, the quality of the reads was verified using FASTQC version 0.11.4100 (no reads flagged as poor 
quality or as containing adapter sequences were used in downstream analyses).
Expression quantification and principal component analysis (PCA). All reads were aligned to the 
T. urticae genome62 using the two-pass alignment mode of STAR 2.5.0a101 with a maximum intron size set to 
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20 kb. Resulting BAM files were subsequently sorted on read name by using SAMtools 0.1.19102. Read counts per 
gene using the most recent T. urticae annotation (version of June 23, 2016) were then obtained using the default 
settings of HTSeq. 0.6.0103 with the “STRANDED” flag set to “yes” and the “feature” flag set to “exon”. A PCA was 
created as described by Love et al.104. Briefly, read counts were first normalized using the regularized-logarithm 
(rlog) transformation implemented in the DESeq2 (version 1.12.2) R-package105. A PCA was then performed 
using the stats (version 3.3.0) and ggplot2 (version 2.2.0) R-packages with the 5000 most variable genes across all 
RNA-seq samples.
Differential expression (DE) analysis and gene ontology (GO) enrichment analysis. A differen-
tial expression (DE) analysis was performed using DESeq2 (version 1.12.2)105 and the read count data obtained 
by HTSeq (see above). Differentially expressed genes (DEGs, fold change (FC) ≥ 1.5 and Benjamini-Hochberg106 
adjusted p-value < 0.05) were determined between unsprayed mites (CON), mites treated with DEF, DEM, PBO 
or CsA and mites treated with formulation (FORM) (five DE comparisons in total: FORM vs. CON, DEF vs. 
FORM, DEM vs. FORM, PBO vs. FORM and CsA vs. FORM). For the GO enrichment analysis, the complete T. 
urticae proteome (19087 sequences, version of June 23, 2016) was first used as query in a blastp search against the 
non-redundant protein database in NCBI (version of October 31, 2016) using the following settings “ -outfmt 
5 -evalue 1e-5 -word_size 3 -show_gis -num_alignments 20 -max_hsps_per_subject 20”. The resulting blastp 
output was then loaded into the Blast2GO (version 4.0.7) program107 and T. urticae proteins were annotated 
using the default parameters107. InterProScan 5 and ANNEX were used to augment the annotation of GO terms. 
GO terms were condensed using the generic GO Slim subset. For the DESeq2 output of four DE comparisons 
(DEF vs. FORM, DEM vs. FORM, PBO vs. FORM and CsA vs. FORM), a GO enrichment analysis was per-
formed using the Bioconductor package GOSeq (version 1.24.0)108, which explicitly takes into account gene selec-
tion bias due to differences in transcript length109. The resulting p-values from GOSeq were corrected using the 
Benjamini-Hochberg method106 and only those GO categories with an adjusted p-value of less than 0.05 were 
considered significantly enriched. Gene expression heatmaps were generated using the relative transcript levels 
(fold changes) of four DE comparisons (DEF vs. FORM, DEM vs. FORM, PBO vs. FORM and CsA vs. FORM) 
and the limma (version 3.28.21) and gplots (version 3.0.1) packages in the R environment. Transcription fac-
tor, P450 and UGT gene lists were obtained from previous studies62,78,110 while the MFS gene list consisted of 
those from Dermauw et al.44 and those that were differentially expressed in the CsA treatment (Supplementary 
Table S6). Genes with no read counts in all four DE comparison were not included in the heatplot. Finally, genes 
were clustered using a Euclidean distance metric and Ward’s method.
qPCR. To validate the RNA-seq results, gene specific primers were designed for differentially expressed T. 
urticae genes (8 up- and 5 downregulated genes) using Primer 3 v.4.0.0111. The qPCR primers used, including the 
primers for the genes of interest, as well as those for the two reference genes, ribosomal protein gene RP49 and 
ubiquitin, can be found in Supplementary Table S8. Total RNA was extracted as described above and cDNA was 
synthesized with the Maxima First Strand cDNA kit (Fermentas Life Sciences, Aalst, Belgium) and 1.5 µg of total 
RNA. Three biological and two technical replicates were used and non-template controls were added to exclude 
sample contamination. The qPCR analysis was performed on a Mx3005 P qPCR thermal cycler (Stratagene, 
Agilent Technologies, Diegem, Belgium) with Maxima SYBR Green qPCR Master Mix and ROX solution 
(Fermentas Life Sciences) according to the manufacturer’s instructions. The run conditions were as follows: 95 °C 
for 10 m followed by 35 cycles of 95 °C for 15 s, 55 °C for 30 s, 72 °C for 30 s. At the end of these cycles, a melting 
curve was generated (from 65 °C to 95 °C, 1 °C per 2 s) to check the presence of a single amplicon. Fourfold dilu-
tion series of pooled cDNA were used to determine the standard curves and amplification efficiencies for every 
gene-specific primer pair. The efficiencies were incorporated in the calculations of the expression values. Relative 
expression levels and significant gene expression differences (one-sided unpaired t-test) were calculated with 
qbase+ version 3.0112.
Image processing. CorelDRAW Home & Student ×7 and SigmaPlot 12.0 software was used for processing 
of images.
Data availability. The RNA-seq expression data generated during the current study are available in the 
Gene-Expression Omnibus (GEO) repository with accession number  GSE98293.
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